ReviewArchives of biochemistry and biophysics2026
Interplay between NRF2 post-translational modifications and protein-protein interactions: Perspectives from emerging structural and functional evidence.
Review in Archives of biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nuclear factor erythroid 2-related factor 2 (NRF2), a redox-sensitive transcription factor, is a master regulator of cellular adaptation to diverse types of stressors. Under basal conditions, the regulation of NRF2 is governed by Kelch-like ECH-associated protein 1 (KEAP1), an adaptor subunit of the CUL3-based E3 ubiquitin ligase, which promotes the ubiquitination and subsequent degradation of NRF2. However, when electrophilic or oxidative stressors alter the conformation of the KEAP1-NRF2 complex, KEAP1 loses its regulatory control over newly synthesized NRF2, leading to its accumulation and nuclear translocation, where it exerts transcriptional activity. NRF2 stability and activity are also shaped by a broader spectrum of protein-protein interactions (PPIs), including recently emerging regulators such as peptidyl prolyl isomerase (PIN1). Significantly, many of these dynamic PPI networks are regulated by post-translational modifications (PTMs), which, in turn, can be governed by these PPIs. While major PTMs such as phosphorylation and ubiquitination constitute the central regulatory processes, atypical or less-characterized modifications, including SUMOylation and O-GlcNAcylation, are gaining increasing attention for their tissue and condition-specific roles. This review compiles the latest structural and functional evidence on well-known as well as understudied PTMs and PPIs of NRF2, emphasizing the dynamic interplay between these regulatory mechanisms in shaping NRF2 signaling under physiological and stress conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.